An Official Website of the United States Government
Company Information:
Name:
ENDOPROTECH, INC.
Address:
1044 E CHESTNUT ST
LOUISVILLE, KY 40204-1019
LOUISVILLE, KY 40204-1019
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
New anti-complement therapy to reduce reperfusion injury
Award Year / Program / Phase:
2005 / STTR / Phase I
Agency:
HHS
Research Institution:
UNIVERSITY OF LOUISVILLE
Abstract:
DESCRIPTION (provided by applicant):
The purpose of this proposal is to provide proof-of-concept that a novel therapy that prevents complement activation could be effective in reducing ischemia reperfusion injury (IRI) in transplanted organs. Complement activation after IRI in transplanted organs… More
New anti-complement therapy to reduce reperfusion injury: Phase II
Award Year / Program / Phase:
2008 / STTR / Phase II
Agency:
HHS
Research Institution:
N/A
Principal Investigator:
Award Amount:
$963,666.00
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): Tissue and organ transplantation procedures save and/or improve the lives of hundred of thousands of patients annually in the US. The goal of this research is to develop a local anti-complement therapy for donor organ e
x vivo application that will reduce… More
Device for Delivery of Rolipram to Liver for Treatment of Alcoholic Liver Disease
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Philip Bauer – 502-569-1020
Award Amount:
$277,707.00
Abstract:
DESCRIPTION (provided by applicant): Alcoholic Liver Disease (ALD) remains a leading cause of death from liver disease in the U.S., and there is still no FDA-approved therapy. Abnormal cytokine metabolism is a major feature of ALD. Elevated serum concentrations of tumor necrosis factor (TNF-) and… More